MASHINIi

DRAEGERWERK ST.A.

DRW8.XETRA | Manufacture of medical and dental instruments and supplies

Drägerwerk AG & Co. KGaA is a German company specializing in medical and safety technology. The company develops, manufactures, and markets equipment and systems for respiratory protection, gas detection, and patient monitoring. Its products are used in hospitals, fire departments, mining, and other...Show More

Ethical Profile

Mixed.

Drägerwerk presents a mixed ethical record. The company has donated approximately $33.2 million in medical equipment to developing countries. However, it faced a Class I recall for 703 Carina Ventilators in the US due to alleged carcinogen exposure, and a Class 2 recall for Atlan anesthesia machines. Environmentally, Drägerwerk targets net-zero by 2045, with its UK subsidiary reportedly achieving 100% renewable energy and significant emissions reductions. Its Lübeck site boasts a 95.7% waste diversion rate. In sourcing, 70% of purchasing volume was covered by their Supplier Code of Conduct in 2020, though detailed enforcement data is limited. The company also secured a $57.4 million DoD contract. While prioritizing cybersecurity, vulnerabilities were identified in some patient monitors in 2018, which were later addressed.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing-20
-100100
Honest & Fair Business0
-100100
Kind to Animals0
-100100
No War, No Weapons-40
-100100
Planet-Friendly Business-40
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech10
-100100
Zero Waste & Sustainable Products-20
-100100

Better Health for All

0

Drägerwerk has had two Class I product recalls within the past three years. In July 2023, 703 Carina Ventilators in the US were subject to a Class I recall due to contaminants emitting a potential carcinogen, with pediatric patients identified as vulnerable.

1
In February 2024, Atlan A350 and A350 XL anesthesia machines were subject to a recall
2
that the FDA later identified as the most serious type in October 2024, citing potential for serious injury or death due to ventilator failure.
3
No reported injuries or deaths were associated with these specific recalls.
4
The company demonstrated transparency by issuing an "Urgent Medical Device Recall Letter" for the Carina Ventilators
5
and an "Urgent Medical Device Correction" for the Atlan anesthesia machines, including instructions for use and supervision.
6
The company's core business involves medical and safety technology, including respiratory protection, gas detection, patient monitoring, anesthesia, and ventilation, which inherently provide substantial health benefits. There is no evidence of revenue from products with well-established negative health outcomes.

Fair Money & Economic Opportunity

0

Drägerwerk AG & Co. KGaA is a medical and safety technology company, not a financial institution. The company does not offer lending, deposit services, or other financial products to consumers. As such, all Key Performance Indicators related to fair money and economic opportunity, including underserved client share, pricing fairness, exploitative fee exposure, and financial literacy initiatives, are not applicable to its business model, as explicitly stated in its 2021 sustainability report.

1

Fair Pay & Worker Respect

0

No specific quantitative data was found in the provided articles for any of the KPIs related to Fair Pay & Worker Respect for DRW8.XETRA. While the company is included in the Global Challenges Index, which excludes companies with severe violations of ILO principles, and achieved EcoVadis 'Silver' status with 72 out of 100 points in 2024

1
, these do not provide the specific metrics required by the rubric for scoring. Drägerwerk has an Integrity Channel for reporting compliance violations
2
and a system for human rights and environmental complaints
3
. It also has a goal for Lost Time Injury Rate (LTIR) to be less than 4.0
4
and a diversity goal of 30% women in management positions by 2035
5
, but these are future targets or mechanisms, not current performance metrics.

Fair Trade & Ethical Sourcing

-20

70% of the company's purchasing volume is covered by its Supplier Code of Conduct, which aims to prevent modern slavery and human trafficking

1
. Dräger UK & Ireland requires its suppliers to sign a 'Supplier Agreement' confirming compliance with the Modern Slavery Act 2015
2
. The company also maintains a compliance reporting system for concerns related to slavery and human trafficking
3
.

Honest & Fair Business

0

Drägerwerk AG & Co. KGaA has an ESG Controversy Level of None.

1
The company reported zero ethics-related regulatory fines in the past three years.
2
Its transparency, as measured by EcoVadis in 2024, scored 72 out of 100 points.
3
Dräger maintains a comprehensive Compliance Management System (CMS) that covers anti-corruption, including detailed policies and training.
4
The company has a whistleblower policy, the 'Dräger Integrity Channel,' which is a web-based reporting channel available 24/7 worldwide, allows for anonymous reporting, and the company states it does not tolerate reprisals against those who report in good faith.
5
Reports are reviewed by the Corporate Compliance Office.
6

Kind to Animals

0

No specific, concrete evidence was found in the provided articles to assess Drägerwerk AG & Co. KGaA against any of the 'Kind to Animals' KPIs. The articles explicitly state a lack of data for all relevant metrics, including cruelty-free certifications, alternative testing usage, humane certifications, wildlife conservation impact, ethical input substitution, supplier audits, cage-free sourcing, animal testing policy or volume, innovation investment in animal-free technologies, animal agriculture ethics, animal-free R&D collaboration, and public policy engagement on animal welfare.

1
,
2

No War, No Weapons

-40

Dräger Medical secured a $57.4 million contract with the US Department of Defense

1
, which represents approximately 1.565% of the company's 2023 net sales of €3,373.5 million.
2
The company's Supplier Code of Conduct, addressing anti-slavery and human trafficking, covers approximately 70% of its purchasing volume.
3
Dräger also has a "Declaration of Principles on Respect for Human Rights" that outlines expectations for employees and business partners
4
, detailing how the company identifies risks and implements measures to prevent human rights violations.
5

Planet-Friendly Business

-40

The company has a stated net-zero carbon target year of 2045.

1

Respect for Cultures & Communities

0

The provided articles, including DRW8.XETRA's own annual report, explicitly state a lack of specific quantitative data for any of the KPIs related to 'Respect for Cultures & Communities'.

1
The annual report () notes data gaps for formal partnerships, revenue reinvestment, cultural appropriation incidents, cultural impact assessment protocols, local employment ratios, grievance mechanisms, complaint resolution times, FPIC participation rates, community governance inclusion, cultural preservation investment, local procurement, indigenous supplier count, cultural site protection, social license to operate, charitable giving, community fund allocation, language inclusivity, cultural incident response, and cultural training completion.
2
Articles
3
,
4
discuss general diversity and inclusion metrics but explicitly state they do not provide company-specific data for DRW8.XETRA.
5
,
6

Safe & Smart Tech

10

Dräger demonstrates excellent data minimization practices, retaining log files for up to 30 days, application data for up to three months, and various marketing/analytics data for periods ranging from one month to 24 months, based on necessity.

1
The company has a coordinated vulnerability disclosure webpage
2
and actively remediated three identified vulnerabilities in patient monitors with a software update in December 2018.
3
Dräger employs various security testing methods, including vulnerability and compliance scanning, fuzz testing, penetration testing, and static code analysis.
4
Users are provided with comprehensive data control rights, including access, rectification, erasure, restriction of processing, withdrawal of consent, data portability, and objection, with a dedicated contact for exercising these rights.
5
The company states compliance with GDPR, California privacy laws, and the California Transparency in Supply Chains Act.
6
Dräger also has a "Declaration of Principles on Respect for Human Rights."
7
Data is automatically encrypted during transmission
8
and used for authentication and data transfers.
9
There are no documented incidents of unauthorized data use or data breaches. Authentication controls include strong passwords, session timeouts, encrypted authentication, and secure boot, but specific MFA availability is not detailed.
10
The company mentions bug bounty programs but provides no details on their effectiveness.
11

Zero Waste & Sustainable Products

-20

The company achieved a waste diversion rate of 95.7% at its Lübeck site in 2023.

1
No waste disposal violations were reported in 2023.
2
The Code of Conduct for Business Partners, which includes waste reduction and recyclability requirements, covered 88% of suppliers in 2022.
3
Waste reduction measures have been implemented at various production sites, including a 40% reduction in the activated carbon production department.
4
Regular internal and external environmental audits review waste disposal processes.
5

Own DRAEGERWERK ST.A?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.